ANTIBODY RESPONSES AND PROTECTION FROM PYELONEPHRITIS FOLLOWING VACCINATION WITH PURIFIED ESCHERICHIA COLI PAPDG PROTEIN
Open accessThe DOI matches its Crossref record.
Abstract
PURPOSE: A critical early step in the establishment of Escherichia coli pyelonephritis is bacterial attachment via the tip protein of P fimbriae. This adhesin, PapG, binds to glycolipid receptors present on vaginal and kidney epithelial surfaces. In this study we investigated the efficacy of vaccination with purified PapDG protein complex in preventing pyelonephritis caused by E. coli. MATERIALS AND METHODS: Mature cynomolgus monkeys were intraperitoneally vaccinated with 100 microg purified PapDG protein. Following 3 identical boosters serum antibody titers to PapDG were measured by enzyme-linked immunosorbent assay. Vaccinated and unvaccinated animals were urethrally inoculated with 1 x 10 cfu of E. coli strain DS17, which was isolated from a child with acute pyelonephritis. The infection course was monitored by catheterized urine cultures, and by histological examination of the kidneys, bladder and kidney tissue culture 28 days after infection. RESULTS: Intraperitoneal administration of purified PapDG vaccine resulted in the development of specific antibody responses in cynomolgus monkeys. In contrast to control monkeys, vaccinated monkeys did not show histological evidence of pyelonephritis after subsequent urethral challenge with pyelonephritogenic E. coli expressing P fimbriae. CONCLUSIONS: Purified PapDG is a tractable vaccine candidate that in our small study demonstrated the ability to elicit adequate serum antibody levels to prevent E. coli mediated pyelonephritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3432 · Cited by 4,213
Self-citationCarbohydrates as future anti-adhesion drugs for infectious diseases
Sharon, N. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.008 · Cited by 512
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
Zowawi, H. M., Harris, P. N. A., Roberts, M. J., Tambyah, P. A., Schembri, M. A., Pezzani, M. D., Williamson, D. A., & Paterson, D. L. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.199 · Cited by 361
Nonantibiotic prevention and management of recurrent urinary tract infection
Sihra, N., Goodman, A., Zakri, R., Sahai, A., & Malde, S. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0106-x · Cited by 307
Zhou, Y., Zhou, Z., Zheng, L., Gong, Z., Li, Y., Jin, Y., Huang, Y., & Chi, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310537 · Cited by 305
Metadata
- Authors
- ROBERTS, J. A., KAACK, M. B., BASKIN, G., CHAPMAN, M. R., HUNSTAD, D. A., PINKNER, J. S., & HULTGREN, S. J.
- Venue
- Journal of Urology
- Published
- 2004-04
- Volume
- 171
- Issue
- 4
- Pages
- 1682-1685
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2129026971
- Cited by
- 106
- References
- 0
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ANTIBODY RESPONSES AND PROTECTION FROM PYELONEPHRITIS FOLLOWING VACCINATION WITH PURIFIED ESCHERICHIA COLI PAPDG PROTEIN. https://app.cochat.ai/papers/10.1097/01.ju.0000116123.05160.43
- The paper
- ROBERTS, J. A., KAACK, M. B., BASKIN, G., CHAPMAN, M. R., HUNSTAD, D. A., PINKNER, J. S., & HULTGREN, S. J. (2004). ANTIBODY RESPONSES AND PROTECTION FROM PYELONEPHRITIS FOLLOWING VACCINATION WITH PURIFIED ESCHERICHIA COLI PAPDG PROTEIN. Journal of Urology. https://doi.org/10.1097/01.ju.0000116123.05160.43
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.